Image-guided, focused ultrasound-triggered drug delivery technology for brain cancers

Thanou, Maya (Primary Investigator)
Pouliopoulos, Antonios (Co-Investigator)

Project: Research

Acronym	IFBRAIN
Status	Finished
Effective start/end date	1/06/2022 → 30/11/2024

Collaborative partners

King's College London
Apeikon Therapeutics Ltd (lead)
Pharmidex Pharmaceutical Services Ltd

Funding

TSB Technology Strategy Board: £323,756.00